MoonH.J., KimE.K., KwakJ.Y.Malignancy risk stratification in thyroid nodules with benign results on cytology: combination of thyroid imaging reporting and data system and bethesda system.Ann Surg Oncol2014; 21: 1898–903.
2.
GweonH.M., SonE.J., YoukJ.H.Thyroid nodules with Bethesda system III cytology: can ultrasonography guide the next step?Ann Surg Oncol2013; 20: 3083–8.
3.
HorvathE., MajlisS., RossiR.An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management.J Clin Endocrinol Metab2009; 94: 1748–51.
4.
KwakJ.Y., HanK.H., YoonJ.H.Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk.Radiology2011; 260: 892–9.
5.
HoA.S., SartiE.E., JainK.S.Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).Thyroid2011; 24: 832–9.
6.
NagarkattiS.S., FaquinW.C., LubitzC.C.Management of thyroid nodules with atypical cytology on fine-needle aspiration biopsy.Ann Surg Oncol2013; 20: 60–5.
7.
VanderLaanP.A., MarquseeE., KraneJ.F.Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance.Am J Clin Pathol2011; 136: 572–7.
8.
MaiaF.F., MatosP.S., PavinE.J.Thyroid imaging reporting and data system score combined with Bethesda system for malignancy risk stratification in thyroid nodules with indeterminate results on cytology.Clin Endocrinol (Oxf)2014; 82: 439–44.
